GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
45 hedge funds and large institutions have $14.6M invested in Aevi Genomic Medicine Inc in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
45
Holding in Top 10
–
Calls
$12K
Puts
–
Top Buyers
| 1 | +$4.08M | |
| 2 | +$93.8K | |
| 3 | +$28K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$16.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13K |
Top Sellers
| 1 | -$590K | |
| 2 | -$245K | |
| 3 | -$195K | |
| 4 |
NCMW
Northern Capital Management (Wisconsin)
Madison,
Wisconsin
|
-$192K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$74K |